WPI Nano Life Science Institute, Kanazawa University

International Symposium on Tumor Biology in Kanazawa 2019 will be held on October 29

Kanazawa University Cancer Research Institute and Kanazawa Association of Tumor Biologists will jointly hold a symposium as below.

Date

October 29, 2019, 9:00-16:45

Venue

Memorial Hall, School of Medicine, Kanazawa University

Organizers

Cancer Research Institute, Kanazawa University (KU CRI)
Kanazawa Association of Tumor Biologists

Co-Organizers

Nano Life Science Institute, Kanazawa University (WPI-NanoLSI)
Institute for Frontier Science Initiative, Kanazawa University (InFiniti), etc.

Program

9:00‐9:10 Opening Remarks
Atsushi Hirao, Director of KU CRI and Principal Investigator of WPI-NanoLSI, Kanazawa University

SESSION  1

Chair: Takeshi Suzuki, KU CRI and InFiniti

9:10-9:35 Targeting mitochondrial enzumes of one-carbon metabolism for cancer treatment
Tatsunori Nishimura, KU CRI

9:35-10:00 RB1 inactivation induces a protumoral microenvironment
Chiaki Takahashi, KU CRI

10:00-10:30 Genomic and Epigenomic Alterations in Gastrointestinal Cancer: Opportunitites for Precision Oncology
Patrik Tan, Duke-NUS Medical School, Singapore

10:30-10:40 Coffee Break

SESSION  2

Chair: Naofumi Mukaida, KU CRI

10:40-11:05 Regulation of hematopoietic stem cell fate by gut microbiota-derived metabolites
Yuko Tadokoro, KU CRI and WPI-NanoLSI

11:05-11:30 Macrocyclic peptide targeting growth factor and the receptor
Kunio Matsumoto, KU CRI, WPI-NanoLSI, and InFiniti

11:30-12:00 The potential role of multi-drug resistance protein ABCB1 for tumor  suppression in bats.
Koji Itahana, Duke-NUS Medical School, Singapore

12:00-13:00 Lunch

SPECIAL LECTURE

Chair: Masanobu Oshima, KU CRI and WPI-NanoLSI

13:00-13:50 Drugging the Wnt pathway – Where it helps, and what it teaches us.
David Virshup, Duke-NUS Medical School, Singapore

13:50-14:00 Coffee Break

SESSION  3

Chair: Toshinari Minamoto, KU CRI

14:00-14:25 Protective role of JLP-dependent lysosomme positioning in reactive oxygen species (ROS)-induced cell death
I Ketut Gunarta, KU CRI

14:25-14:50 Circumvention of targeted drug tolerance in lung cancer
Seiji Yano, KU CRI and WPI-NanoLSI

14:50-15:20 The polycomb repressive complex drives epigenetic convergence in blast crisis chronic myeloid leukemia
S. Tiong Ong, Duke-NUS Medical School, Singapore

15:20-15:35 Coffee Break

SESSION  4

15:35-16:00 CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functinoal validation for colorectal cancer driver genes.
Haruna Takeda, National Cancer Center Japan

16:00-16:25 The mechanism and physiological significance of programmed cell death initiated by caspase-1
Kohsuke Tsuchiya, KU CRI and InFiniti

16:25-16:35 External Panel Review

16:35-16:45 Closing Remarks
Chisato Mukai, Vice President of Kanazawa University

16:45-16:50 Photo session

 

Poster can be downloaded from here.

 PAGE TOP